0001826133-21-000002.txt : 20210111 0001826133-21-000002.hdr.sgml : 20210111 20210111164013 ACCESSION NUMBER: 0001826133-21-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210108 FILED AS OF DATE: 20210111 DATE AS OF CHANGE: 20210111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parkinson Paul CENTRAL INDEX KEY: 0001826133 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 21521245 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-01-08 0 0000899923 MYRIAD GENETICS INC MYGN 0001826133 Parkinson Paul 320 WAKARA WAY SALT LAKE CITY UT 84108 0 1 0 0 EVP Strategy and Innovation Common Stock 2021-01-08 4 S 0 11824 25.0 D 76746 D This transaction was effected pursuant to a Rule 10b5-1 trading plan. By: Nathan A. Smith For: Paul Parkinson 2021-01-11